ACET

Adicet Bio, (ACET)

About Adicet Bio, (ACET)

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Details

Daily high

$1.44

Daily low

$1.36

Price at open

$1.41

52 Week High

$3.77

52 Week Low

$1.05

Market cap

114.5M

Dividend yield

0.00%

Volume

244,079

Avg. volume

513,567

P/E ratio

-.55

Adicet Bio, News